Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
Titel:
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial
Auteur:
Lannfelt, Lars Blennow, Kaj Zetterberg, Henrik Batsman, Stellan Ames, David Harrison, John Masters, Colin L Targum, Steve Bush, Ashley I Murdoch, Ross Wilson, Janet Ritchie, Craig W